This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human GDNF DuoSet ELISA
catalog :
DY212
quantity :
1 Kit (for 15 Plates)
price :
850 USD
citations: 39
Reference
Ribeiro R, Silva E, Moreira F, Gomes G, Cussat G, Silva B, et al. Chronic hyperpalatable diet induces impairment of hippocampal-dependent memories and alters glutamatergic and fractalkine axis signaling. Sci Rep. 2023;13:16358 pubmed publisher
Ford M, George B, Van Laar V, Holleran K, Naidoo J, Hadaczek P, et al. GDNF gene therapy for alcohol use disorder in male non-human primates. Nat Med. 2023;29:2030-2040 pubmed publisher
Novosadova E, Dolotov O, Novosadova L, Davydova L, Sidoruk K, Arsenyeva E, et al. Composite Coatings Based on Recombinant Spidroins and Peptides with Motifs of the Extracellular Matrix Proteins Enhance Neuronal Differentiation of Neural Precursor Cells Derived from Human Induced Pluripotent Stem Cells. Int J Mol Sci. 2023;24: pubmed publisher
Escobar A, Carvalho M, Maia F, Reis R, Silva T, Oliveira J. Glial Cell Line-Derived Neurotrophic Factor-Loaded CMCht/PAMAM Dendrimer Nanoparticles for Peripheral Nerve Repair. Pharmaceutics. 2022;14: pubmed publisher
Baloh R, Johnson J, Avalos P, Allred P, Svendsen S, Gowing G, et al. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial. Nat Med. 2022;28:1813-1822 pubmed publisher
Szpakowski P, Ksiazek Winiarek D, Turniak Kusy M, Pacan I, Glabinski A. Human Primary Astrocytes Differently Respond to Pro- and Anti-Inflammatory Stimuli. Biomedicines. 2022;10: pubmed publisher
Khaleel B, Lunenfeld E, Kapelushnik J, Huleihel M. Effect of Chemotherapy Cytarabine and Acute Myeloid Leukemia on the Development of Spermatogenesis at the Adult Age of Immature Treated Mice. Int J Mol Sci. 2022;23: pubmed publisher
Islamov R, Bashirov F, Izmailov A, Fadeev F, Markosyan V, Sokolov M, et al. New Therapy for Spinal Cord Injury: Autologous Genetically-Enriched Leucoconcentrate Integrated with Epidural Electrical Stimulation. Cells. 2022;11: pubmed publisher
Lee H, Yeum C, Lee H, Oh J, Kim J, Lee W, et al. Peripheral Nerve-Derived Stem Cell Spheroids Induce Functional Recovery and Repair after Spinal Cord Injury in Rodents. Int J Mol Sci. 2021;22: pubmed publisher
von Kanel R, Hamer M, Wentzel A, Malan L. Circulating neurotrophins and hemostatic risk factors of atherothrombotic cardiovascular disease at baseline and during sympathetic challenge: the SABPA study. Sci Rep. 2021;11:2297 pubmed publisher
Chenlo M, Rodriguez Gomez I, Serramito R, Garcia Rendueles A, Villar Taibo R, Fernandez Rodriguez E, et al. Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly. EBioMedicine. 2019;43:537-552 pubmed publisher
Paolone G, Falcicchia C, Lovisari F, Kokaia M, Bell W, Fradet T, et al. Long-Term, Targeted Delivery of GDNF from Encapsulated Cells Is Neuroprotective and Reduces Seizures in the Pilocarpine Model of Epilepsy. J Neurosci. 2019;39:2144-2156 pubmed publisher
Chu C, Chu C, Wu C, Lu T. Serum nerve growth factor beta, brain- and glial-derived neurotrophic factor levels and psychopathology in unmedicated patients with schizophrenia. J Chin Med Assoc. 2018;81:577-581 pubmed publisher
Gothelf Y, Kaspi H, Abramov N, Aricha R. miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors. Stem Cell Res Ther. 2017;8:249 pubmed publisher
Stefani M, Modkovski R, Hansel G, Zimmer E, Kopczynski A, Muller A, et al. Elevated glutamate and lactate predict brain death after severe head trauma. Ann Clin Transl Neurol. 2017;4:392-402 pubmed publisher
Baranov P, Lin H, McCabe K, Gale D, Cai S, Lieppman B, et al. A Novel Neuroprotective Small Molecule for Glial Cell Derived Neurotrophic Factor Induction and Photoreceptor Rescue. J Ocul Pharmacol Ther. 2017;33:412-422 pubmed publisher
Li Z, Li X, Chan M, Wu W, Tan D, Shen J. Melatonin antagonizes interleukin-18-mediated inhibition on neural stem cell proliferation and differentiation. J Cell Mol Med. 2017;21:2163-2171 pubmed publisher
Thomsen G, Alkaslasi M, Vit J, Lawless G, Godoy M, Gowing G, et al. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1G93A ALS rat but has adverse side effects. Gene Ther. 2017;24:245-252 pubmed publisher
Cordeiro C, Vieira E, Rocha N, Castro V, Oréfice J, Barichello T, et al. Serum levels of neurotrophic factors in active toxoplasmic retinochoroiditis. Braz J Infect Dis. 2017;21:176-179 pubmed publisher
Zhu L, Su Q, Jie X, Liu A, Wang H, He B, et al. NG2 expression in microglial cells affects the expression of neurotrophic and proinflammatory factors by regulating FAK phosphorylation. Sci Rep. 2016;6:27983 pubmed publisher
Yurek D, Hasselrot U, Cass W, Sesenoglu Laird O, Padegimas L, Cooper M. Age and lesion-induced increases of GDNF transgene expression in brain following intracerebral injections of DNA nanoparticles. Neuroscience. 2015;284:500-12 pubmed publisher
Kim K, Lee H, An J, Kim Y, Ra J, Lim I, et al. Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model. Cell Transplant. 2014;23:1585-97 pubmed publisher
Zhang L, Li K, Liu X, Li D, Luo C, Fu B, et al. Repeated systemic administration of human adipose-derived stem cells attenuates overt diabetic nephropathy in rats. Stem Cells Dev. 2013;22:3074-86 pubmed publisher
Ohshima Hosoyama S, Simmons H, Goecks N, Joers V, Swanson C, Bondarenko V, et al. A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys. PLoS ONE. 2012;7:e39036 pubmed publisher
Touchard E, Heiduschka P, Berdugo M, Kowalczuk L, Bigey P, Chahory S, et al. Non-viral gene therapy for GDNF production in RCS rat: the crucial role of the plasmid dose. Gene Ther. 2012;19:886-98 pubmed publisher
Jones J, Anderson J, Phuah C, Fox E, Selmaj K, Margolin D, et al. Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity. Brain. 2010;133:2232-47 pubmed publisher
Glavaski Joksimovic A, Virag T, Mangatu T, McGrogan M, Wang X, Bohn M. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease. J Neurosci Res. 2010;88:2669-81 pubmed publisher
Han Y, Chang Q, Virag T, West N, George D, Castro M, et al. Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors. Gene Ther. 2010;17:616-25 pubmed publisher
Hadaczek P, Johnston L, Forsayeth J, Bankiewicz K. Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain. Neuropharmacology. 2010;58:1114-21 pubmed publisher
Emborg M, Moirano J, Raschke J, Bondarenko V, Zufferey R, Peng S, et al. Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neurobiol Dis. 2009;36:303-11 pubmed publisher
Mertens B, Massie A, Michotte Y, Sarre S. Effect of nigrostriatal damage induced by 6-hydroxydopamine on the expression of glial cell line-derived neurotrophic factor in the striatum of the rat. Neuroscience. 2009;162:148-54 pubmed publisher
Suzuki M, McHugh J, Tork C, Shelley B, Hayes A, Bellantuono I, et al. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther. 2008;16:2002-10 pubmed publisher
Wang Y, Wu Y, Huang H, Lin H, Lo L, Tzeng S, et al. Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury. Biomaterials. 2008;29:4546-53 pubmed publisher
Sajadi A, Bensadoun J, Schneider B, Lo Bianco C, Aebischer P. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease. Neurobiol Dis. 2006;22:119-29 pubmed
Caggiula M, Batocchi A, Frisullo G, Angelucci F, Patanella A, Sancricca C, et al. Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy. Clin Immunol. 2006;118:77-82 pubmed
Puskovic V, Wolfe D, Goss J, Huang S, Mata M, Glorioso J, et al. Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo. Mol Ther. 2004;10:67-75 pubmed
Yu G, Xu L, Hadman M, Hess D, Borlongan C. Intracerebral transplantation of carotid body in rats with transient middle cerebral artery occlusion. Brain Res. 2004;1015:50-6 pubmed
Truckenmiller M, Vawter M, Zhang P, Conejero Goldberg C, Dillon Carter O, Morales N, et al. AF5, a CNS cell line immortalized with an N-terminal fragment of SV40 large T: growth, differentiation, genetic stability, and gene expression. Exp Neurol. 2002;175:318-37 pubmed
Bensadoun J, Deglon N, Tseng J, Ridet J, Zurn A, Aebischer P. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp Neurol. 2000;164:15-24 pubmed
product information
master code :
DY212
SKU :
DY212
product name :
Human GDNF DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Human GDNF DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human GDNF.
target :
GDNF
category :
ELISAs
species :
Human
gene symbol :
GDNF
kit type :
Solid Phase Sandwich ELISA
elisaRange :
31.20 - 2000 pg/mL
top caption :
Human GDNF ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
Astrocyte-derived trophic factor, ATF, ATF1, ATF2, glial cell derived neurotrophic factor, glial cell line derived neurotrophic factor, glial cell line-derived neurotrophic factor, HFB1-GDNF, HGDNF, HSCR3
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.